← Leaderboards
John M Littleton
University Of Kentucky
$19,398,400
Attributed
$19,398,400
Total exposure
20
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2005–21$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$19,398,400 · 20
By mechanism
R44$6,429,801 · 4
R01$4,823,498 · 2
R42$3,687,564 · 4
U44$2,483,851 · 1
R41$858,110 · 5
R43$750,700 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Linda P Dwoskin$22,762,643
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPlantsPharmacologic SubstanceAgonistCommercializationMutantProductionBiotechnologyCellsMutagenesisPlant ExtractsPharmacologyTechnologyHigh Throughput ScreeningAnimal ModelScreening ProcedureComplexIn VitroIntellectual PropertyBaseRattusSmall Business Technology Transfer ResearchToxic EffectInhibitor/Antagonist
Grant awards (60)
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$1,016,716
U44 · FY2021 · AA · contact PI
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders$975,562
R44 · FY2021 · AA · contact PI
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads$617,521
R44 · FY2021 · NS · contact PI
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders$890,494
R44 · FY2020 · AA · contact PI
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads$624,004
R44 · FY2020 · NS · contact PI
Novel modulators of the dopamine transporter for alcohol and nicotine use disorders$140,059
R44 · FY2020 · AA · contact PI
Mutant transgenic plant cells as a novel source of drugs$104,999
R44 · FY2019 · AA · contact PI
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$794,605
U44 · FY2018 · AA · contact PI
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles$498,691
R44 · FY2018 · AT · contact PI
Mimicking synuclein toxicity in plant cells to identify novel neuroprotective leads$231,474
R43 · FY2018 · NS · contact PI
Development of JR-220 (4-Chlorobenzylidenamino-guanidine hydrochloride) as a medication for alcohol dependence$672,530
U44 · FY2017 · AA · contact PI
Harvesting specific plant metabolites from hairy root cultures using magnetized nanoparticles$530,326
R44 · FY2017 · AT · contact PI
Mutant transgenic plant cells as a novel source of drugs$489,617
R44 · FY2017 · AA · contact PI
Mutant transgenic plant cells as a novel source of drugs$455,773
R44 · FY2016 · AA · contact PI
Selection-driven plant metabolites for treatment of CNS diseases$98,469
R44 · FY2015 · AA · contact PI
Selection-driven plant metabolites for treatment of CNS diseases$487,620
R44 · FY2014 · AA · contact PI
Harvesting specific plant metabolites from hairy root cultures using magnetized n$189,844
R41 · FY2014 · AT · contact PI
Novel flavonoids as anti-inflammatory agents in alcoholism$150,900
R43 · FY2014 · AA · contact PI
Selection-driven plant metabolites for treatment of CNS diseases$516,666
R44 · FY2013 · AA · contact PI
Novel estrogen receptor ligands from plant genomics$334,116
R42 · FY2012 · AT · contact PI
Alcohol, the vagus nerve and multi-organ inflammation$199,813
R21 · FY2012 · AA · contact PI
Novel estrogen receptor ligands from plant genomics$28,884
R42 · FY2012 · AT · contact PI
Novel estrogen receptor ligands from plant genomics$232,153
R42 · FY2011 · AT · contact PI
Potential anti-relapse drugs: a plant genomics approach$170,984
R42 · FY2011 · AA · contact PI
Alcohol, the vagus nerve and multi-organ inflammation$165,063
R21 · FY2011 · AA · contact PI
Selection-driven plant metabolites for treatment of CNS diseases$136,337
R43 · FY2011 · AA · contact PI
Hypericum extracts as potential anti-relapse medications in alcoholism$370,355
R42 · FY2010 · AA · contact PI
Novel estrogen receptor ligands from plant genomics$138,634
R42 · FY2010 · AT · contact PI
Selection-driven plant metabolites for treatment of CNS diseases$136,337
R43 · FY2010 · AA · contact PI
Potential anti-relapse drugs: a plant genomics approach$110,000
R42 · FY2010 · AA · contact PI
Selection-driven plant metabolites for treatment of CNS diseases$95,652
R43 · FY2010 · AA · contact PI
Hypericum extracts as potential anti-relapse medications in alcoholism$374,855
R42 · FY2009 · AA · contact PI
Potential anti-relapse drugs: a plant genomics approach$340,250
R42 · FY2009 · AA · contact PI
Transgenic plant cells as a source of hepatoprotective drugs$247,230
R42 · FY2009 · AA · contact PI
Hypericum extracts as potential anti-relapse medications in alcoholism$96,439
R42 · FY2009 · AA · contact PI
Potential anti-relapse drugs: a plant genomics approach$84,601
R42 · FY2009 · AA · contact PI
Potential anti-relapse drugs: a plant genomics approach$10,000
R42 · FY2009 · AA · contact PI
Potential anti-relapse drugs: a plant genomics approach$252,137
R42 · FY2008 · AA · contact PI
Transgenic plant cells as a source of hepatoprotective drugs$249,230
R42 · FY2008 · AA · contact PI
Hypericum extracts as potential anti-relapse medications in alcoholism$199,400
R42 · FY2008 · AA · contact PI
Hypericum extracts as potential anti-relapse medications in alcoholism$15,397
R42 · FY2008 · AA · contact PI
Development of screens for drugs in alcohol dependence$651,253
R01 · FY2007 · AA · contact PI
Transgenic plant cells as a source of hepatoprotective drugs$249,230
R42 · FY2007 · AA · contact PI
Hypericum extracts as potential anti-relapse medications in alcoholism$183,669
R42 · FY2007 · AA · contact PI
Development of screens for drugs in alcohol dependence$642,748
R01 · FY2006 · AA · contact PI
Novel estrogen receptor ligands from plant genomics$106,716
R41 · FY2006 · CA · contact PI
Application of plant genomics to alcoholic brain damage$99,914
R41 · FY2006 · AA · contact PI
Development of screens for drugs in alcohol dependence$630,033
R01 · FY2005 · AA
Hippocampal neurotoxicity induced by ethanol withdrawal$368,250
R01 · FY2005 · AA
Development of screens for drugs in alcohol dependence$614,886
R01 · FY2004 · AA
Hippocampal neurotoxicity induced by ethanol withdrawal$368,188
R01 · FY2004 · AA
Potential anti-relapse drugs: a plant genomics approach$107,107
R41 · FY2004 · AA
Transgenic plant cells as source of hepatoprotective dr*$102,889
R41 · FY2004 · AA
Application of plant genomics to alcoholic brain damage$97,370
R41 · FY2004 · AA
Application of plant genomics to alcoholic brain damage$54,270
R41 · FY2004 · AA
Hippocampal neurotoxicity induced by ethanol withdrawal$367,291
R01 · FY2003 · AA
Transgenic plant cells as source of hepatoprotective dr$100,000
R41 · FY2003 · AA
DEVELOPMENT OF SCREENS FOR DRUGS IN ALCOHOL DEPENDENCE$402,606
R01 · FY2002 · AA
DEVELOPMENT OF SCREENS FOR DRUGS IN ALCOHOL DEPENDENCE$390,969
R01 · FY2001 · AA
DEVELOPMENT OF SCREENS FOR DRUGS IN ALCOHOL DEPENDENCE$387,274
R01 · FY2000 · AA